Please use this identifier to cite or link to this item: http://ricaxcan.uaz.edu.mx/jspui/handle/20.500.11845/2597
Full metadata record
DC FieldValueLanguage
dc.contributor46461es_ES
dc.contributor.otherhttps://orcid.org/0000-0002-1995-1696-
dc.coverage.spatialGlobales_ES
dc.creatorLazalde Ramos, Blanca Patricia-
dc.creatorZamora Perez, Ana Lourdes-
dc.creatorOrtega Guerrero, Aymée Ileana-
dc.creatorQuintero Fraire, Saira Zulema-
dc.creatorPalacios Lara, Omar-
dc.creatorQuirarte Báez, Sol María-
dc.creatorGalaviz Hernández, Carlos-
dc.creatorSosa Macías, Martha-
dc.creatorOrtiz García, Yveth Marlene-
dc.creatorMorales Velazquez, Gabriela-
dc.date.accessioned2021-06-17T17:40:04Z-
dc.date.available2021-06-17T17:40:04Z-
dc.date.issued2020-10-
dc.identifierinfo:eu-repo/semantics/publishedVersiones_ES
dc.identifier.issn1096-620Xes_ES
dc.identifier.issn1557-7600es_ES
dc.identifier.urihttp://ricaxcan.uaz.edu.mx/jspui/handle/20.500.11845/2597-
dc.identifier.urihttps://doi.org/10.48779/qdx6-z724-
dc.description.abstractGenomic instability is associated with increased oxidative stress in patients with human immunodeficiency virus (HIV). The aim of this study was to determine the effect of intake of methanolic and aqueous extracts of Rosmarinus officinalis on genomic instability in HIV patients. We studied 67 HIV patients under pharmacological treatment with ATRIPLA who were divided into three groups: group 1, patients under ATRIPLA antiretroviral therapy; group 2, patients with ATRIPLA and rosemary aqueous extract (4 g/L per day); and group 3, patients with ATRIPLA and rosemary methanolic extract (400 mg/day). The genomic instability was evaluated through the buccal micronucleus cytome assay. Oral epithelial cells were taken at the beginning and 1 and 4 months later. The groups that received the pharmacological therapy with ATRIPLA and the complementary therapy with R. officinalis extracts showed a decrease in the number of cells with micronuclei and nuclear abnormalities compared with the group that only received ATRIPLA. The complementary therapy with R. officinalis decreased the genomic instability in HIV patients.es_ES
dc.language.isospaes_ES
dc.publisherMary Ann Liebert, Inc.es_ES
dc.relationhttps://www.liebertpub.com/doi/10.1089/jmf.2019.0199es_ES
dc.relation.urigeneralPublices_ES
dc.rightsAtribución-NoComercial-CompartirIgual 3.0 Estados Unidos de América*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/us/*
dc.sourceJournal of Medicinal Food. Vol. 23, No. 10es_ES
dc.subject.classificationBIOLOGIA Y QUIMICA [2]es_ES
dc.subject.otheroxidative stresses_ES
dc.subject.otherhuman immunodeficiency virus (HIV)es_ES
dc.subject.otherRosmarinus officinalises_ES
dc.titleGenomic Instability Decreases in HIV Patient by Complementary Therapy with Rosmarinus officinalis Extractses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
Appears in Collections:*Documentos Académicos*-- M. en Ciencias y Tecnología Química

Files in This Item:
File Description SizeFormat 
Genomic Instability Decreases in HIV Patient by Complementary.pdf239,25 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons